top of page

Wen Hwa Lee

Chair

Dr Wen Hwa Lee is presently the CEO and Chief Scientist at Action Against Age-Related Macular Degeneration (AAAMD), a research charity focused on tackling the leading cause of legal blindness in the developed world at its earliest stages with maximum affordability and accessibility. He is also a co-director of Oxford Martin School’s Affordable Medicines Programme.

Trained in genetics and molecular/structural biology, Dr Lee is experienced in setting up partnerships and alliances with multiple stakeholders to accelerate discoveries for drug discovery. He has designed and implemented several strategies in two of the largest and most successful international public-private partnerships for drug discovery – the Structural Genomics Consortium (SGC) and the European Lead Factory. Alongside his scientific endeavours, Dr Lee also advised high-level government representatives from different countries and charitable institutions on policy and strategy to integrate scientific, societal, and economic impact.

Wen Hwa Lee

Experience and interests

○ Chair
○ Charity AAAMD
○ Drug discovery
○ Research
○ Science policy

bottom of page